Published in Drug Week, September 14th, 2001
At the 222nd national meeting of the American Chemical Society, held August 26-30, 2001, in Chicago, Illinois, Virginia Tech researchers presented their advancements in the development of such roadblocks.
Monoamine oxidases (MAO) A and B and the neuronal form of nitric oxide synthase (nNOS) are two enzyme systems thought to be involved in neurodegenerative pathways in Parkinson disease. A synthetic compound which inhibits both enzymes,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.